BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.46B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.27B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$887M |
| 4 |
Apple
AAPL
|
+$609M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
+$582M |
Top Sells
| 1 |
Pfizer
PFE
|
+$104M |
| 2 |
Visa
V
|
+$92M |
| 3 |
iShares US Financials ETF
IYF
|
+$83.8M |
| 4 |
Charter Communications
CHTR
|
+$65.8M |
| 5 |
Advanced Micro Devices
AMD
|
+$53.4M |
Sector Composition
| 1 | Technology | 15.84% |
| 2 | Healthcare | 9.89% |
| 3 | Financials | 8.48% |
| 4 | Consumer Discretionary | 7.47% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Vanda Pharmaceuticals
VNDA
$266M
| $314K | ﹤0.01% |
30,298
+18,471
| +156% | +$191K |
|
1902
Catalyst Pharmaceutical
CPRX
$2.44B
| $313K | ﹤0.01% |
81,407
+70,000
| +614% | +$270K |
|
1903
Alamos Gold
AGI
$13.9B
| $313K | ﹤0.01% |
62,683
-1,410
| -2% | -$7.05K |
|
1904
Matthews International
MATW
$763M
| $313K | ﹤0.01% |
12,938
+781
| +6% | +$18.9K |
|
1905
Middlesex Water
MSEX
$971M
| $313K | ﹤0.01% |
5,203
+2,585
| +99% | +$155K |
|
|
SAFE
1906
DELISTED
Safehold Inc.
SAFE
| $313K | ﹤0.01% |
4,947
+1,051
| +27% | +$66.5K |
|
1907
SPDR Dow Jones Global Real Estate ETF
RWO
$1.15B
| $313K | ﹤0.01% |
8,681
-24,149
| -74% | -$869K |
|
1908
MillerKnoll
MLKN
$1.4B
| $311K | ﹤0.01% |
14,007
-28,528
| -67% | -$633K |
|
|
SMAR
1909
DELISTED
Smartsheet Inc.
SMAR
| $310K | ﹤0.01% |
7,480
-71,972
| -91% | -$2.99M |
|
1910
iShares MSCI Pacific ex Japan ETF
EPP
$1.85B
| $310K | ﹤0.01% |
9,146
-18,121
| -66% | -$614K |
|
|
FBC
1911
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $309K | ﹤0.01% |
15,605
-8,782
| -36% | -$174K |
|
1912
Sensient Technologies
SXT
$4.52B
| $309K | ﹤0.01% |
7,096
-5,146
| -42% | -$224K |
|
1913
AZZ Inc
AZZ
$3.52B
| $309K | ﹤0.01% |
10,974
+1,649
| +18% | +$46.4K |
|
1914
John B. Sanfilippo & Son
JBSS
$737M
| $308K | ﹤0.01% |
3,450
+978
| +40% | +$87.4K |
|
1915
Gray Television
GTN
$598M
| $308K | ﹤0.01% |
28,708
+8,561
| +42% | +$91.9K |
|
|
ALEX
1916
Alexander & Baldwin
ALEX
$1.34B
| $308K | ﹤0.01% |
27,477
+3,801
| +16% | +$42.6K |
|
1917
Travere Therapeutics
TVTX
$2.09B
| $307K | ﹤0.01% |
21,061
+16,228
| +336% | +$237K |
|
1918
AnaptysBio
ANAB
$655M
| $306K | ﹤0.01% |
21,688
+18,286
| +538% | +$258K |
|
1919
NMI Holdings
NMIH
$3.08B
| $305K | ﹤0.01% |
26,295
+9,437
| +56% | +$110K |
|
1920
CVR Energy
CVI
$3.13B
| $305K | ﹤0.01% |
18,438
-6,282
| -25% | -$104K |
|
1921
Hancock Whitney
HWC
$5.36B
| $304K | ﹤0.01% |
15,564
-1,245
| -7% | -$24.3K |
|
1922
PJT Partners
PJT
$4.47B
| $304K | ﹤0.01% |
6,996
+2,775
| +66% | +$120K |
|
1923
Fossil Group
FOSL
$168M
| $303K | ﹤0.01% |
92,068
+26,692
| +41% | +$87.8K |
|
1924
National Bank Holdings
NBHC
$1.46B
| $302K | ﹤0.01% |
12,635
+5,209
| +70% | +$124K |
|
1925
Smith & Wesson
SWBI
$415M
| $300K | ﹤0.01% |
47,094
-4,592
| -9% | -$29.3K |
|